World’s biggest insulin producer to ensure success for Novo’s new bet

For almost 50 years, Novo Nordisk’s production facilities have been based in Kalundborg and today, the factory accounts for half of the world’s production of insulin. Moreover, it plays a special part in the distribution of another type of drugs that Novo has spent enormous resources developing. MedWatch brings you behind the scenes of “the world’s largest insulin manufacturer” in terms of production volume.

Photo: Novo Nordisk/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Omstridt parallelimportør går konkurs

Parallelimportøren Europharma, der to gange i 2017 blev suspenderet af Lægemiddelstyrelsen, er gået konkurs. Selskabet har erkendt, at et varelager for 50 mio. kr. er usælgeligt.

Related articles